Genentech
Genentech, Inc.
1 DNA Way,
South San Francisco,
CA 94080
Phone: (650) 225-1000Website: https://www.gene.com/Careers: www.gene.com/careers
Latest news
- FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) Twice-A-Year Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
17 September 2024 - FDA Approves Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
12 September 2024 - Genentech to Reintroduce Susvimo for People With Wet Age-Related Macular Degeneration (AMD)
8 July 2024 - Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer
5 July 2024 - FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss
4 July 2024 - FDA Approves PiaSky (crovalimab-akkz) for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
24 June 2024 - FDA Grants Priority Review to Roche’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
29 May 2024 - FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
28 May 2024 - FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
20 May 2024 - First Patient Dosed in Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer
15 May 2024
Drugs Associated with Genentech, Inc.
Genentech, Inc. manufactures, markets and/or distributes more than 43 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Actemra
Generic name: tocilizumab Drug class: interleukin inhibitors |
43 reviews | 6.9 / 10 |
Activase
Generic name: alteplase Drug class: thrombolytics |
1 review | 10 / 10 |
Alecensa
Generic name: alectinib Drug class: multikinase inhibitors |
2 reviews | 9.5 / 10 |
Avastin
Generic name: bevacizumab Drug class: VEGF/VEGFR inhibitors |
26 reviews | 7.7 / 10 |
Cathflo Activase
Generic name: alteplase Drug class: thrombolytics |
1 review | 10 / 10 |
CellCept
Generic name: mycophenolate mofetil Drug class: selective immunosuppressants |
33 reviews | 8.3 / 10 |
Cotellic
Generic name: cobimetinib Drug class: multikinase inhibitors |
||
Enspryng
Generic name: satralizumab Drug class: interleukin inhibitors |
||
Erivedge
Generic name: vismodegib Drug class: hedgehog pathway inhibitors |
2 reviews | 9.0 / 10 |
Esbriet
Generic name: pirfenidone Drug class: miscellaneous uncategorized agents |
10 reviews | 7.7 / 10 |
Evrysdi
Generic name: risdiplam Drug class: miscellaneous uncategorized agents |
||
Fuzeon
Generic name: enfuvirtide Drug class: miscellaneous antivirals |
5 reviews | 9.4 / 10 |
Gavreto
Generic name: pralsetinib Drug class: multikinase inhibitors |
||
Gazyva
Generic name: obinutuzumab Drug class: CD20 monoclonal antibodies |
||
Hemlibra
Generic name: emicizumab Drug class: miscellaneous coagulation modifiers |
2 reviews | 10 / 10 |
Herceptin
Generic name: trastuzumab Drug class: HER2 inhibitors |
9 reviews | 8.9 / 10 |
Herceptin Hylecta
Generic name: hyaluronidase/trastuzumab Drug class: HER2 inhibitors |
1 review | 10 / 10 |
Kadcyla
Generic name: ado-trastuzumab emtansine Drug class: HER2 inhibitors |
||
Lucentis
Generic name: ranibizumab Drug class: anti-angiogenic ophthalmic agents |
13 reviews | 6.5 / 10 |
Lunsumio
Generic name: mosunetuzumab Drug class: bispecific T-cell engagers (BiTE) |
1 review | 8.0 / 10 |
Nutropin AQ
Generic name: somatropin Drug class: growth hormones |
||
Ocrevus
Generic name: ocrelizumab Drug class: CD20 monoclonal antibodies |
155 reviews | 5.0 / 10 |
Pegasys
Generic name: peginterferon alfa-2a Drug class: antiviral interferons |
12 reviews | 6.5 / 10 |
Perjeta
Generic name: pertuzumab Drug class: HER2 inhibitors |
||
Phesgo
Generic name: hyaluronidase/pertuzumab/trastuzumab Drug class: HER2 inhibitors |
||
PiaSky
Generic name: crovalimab |
||
Polivy
Generic name: polatuzumab vedotin Drug class: miscellaneous antineoplastics |
||
Pulmozyme
Generic name: dornase alfa Drug class: miscellaneous respiratory agents |
1 review | 10 / 10 |
Rituxan
Generic name: rituximab Drug class: antirheumatics, CD20 monoclonal antibodies |
46 reviews | 8.2 / 10 |
Rituxan Hycela
Generic name: hyaluronidase/rituximab Drug class: CD20 monoclonal antibodies |
||
Rozlytrek
Generic name: entrectinib Drug class: multikinase inhibitors |
||
Susvimo
Generic name: ranibizumab Drug class: anti-angiogenic ophthalmic agents |
||
Tamiflu
Generic name: oseltamivir Drug class: neuraminidase inhibitors |
520 reviews | 6.0 / 10 |
Tecentriq
Generic name: atezolizumab Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) |
||
TNKase
Generic name: tenecteplase Drug class: thrombolytics |
||
Vabysmo
Generic name: faricimab Drug class: anti-angiogenic ophthalmic agents |
23 reviews | 8.0 / 10 |
Valcyte
Generic name: valganciclovir Drug class: purine nucleosides |
2 reviews | 5.0 / 10 |
Valium
Generic name: diazepam Drug class: benzodiazepine anticonvulsants, benzodiazepines |
317 reviews | 8.7 / 10 |
Venclexta
Generic name: venetoclax Drug class: miscellaneous antineoplastics |
6 reviews | 8.2 / 10 |
Xeloda
Generic name: capecitabine Drug class: antimetabolites |
28 reviews | 6.6 / 10 |
Xofluza
Generic name: baloxavir marboxil Drug class: miscellaneous antivirals |
26 reviews | 7.7 / 10 |
Xolair
Generic name: omalizumab Drug class: selective immunosuppressants |
201 reviews | 7.6 / 10 |
Zelboraf
Generic name: vemurafenib Drug class: multikinase inhibitors |
4 reviews | 6.2 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
Discontinued Drugs
Brand/Generic Name | Reviews | Rating |
---|---|---|
Tarceva
Generic name: erlotinib Drug class: EGFR inhibitors |
35 reviews | 8.4 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |